Respirology Search
Respirology Respirology
pulmonary%20thromboembolism
PULMONARY THROMBOEMBOLISM
Treatment Guideline Chart
Pulmonary embolism is the blockage of the blood vessels in the lungs usually due to blood clots from the veins, especially the veins in the legs and pelvis.
Dyspnea, chest pain, syncope or tachypnea (respiratory rate of ≥20/min) occur in most cases of pulmonary embolism.
Pleuritic chest pain with or without dyspnea is one of the most frequent presentations of this disease.
Syncope or shock are the hallmark signs of central pulmonary embolism and usually result in severe hemodynamic repercussions.
Signs of hemodynamic compromise and reduced heart flow are also usually present.

Pulmonary Thromboembolism References

  1. Almoosa K. Is thrombolytic therapy effective for the pulmonary embolism?. Am Fam Physician. 2002 Mar;65(6):1097-1102. PMID: 11925086
  2. Büller HR, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease: the seventh ACCP Conference on antithrombotic and thrombolytic therapy. Chest. 2004 Sep;126(3)(Suppl):401S-428S. PMID: 15383479
  3. British Thoracic Society Standards of Care Committee Pulmonary Embolism Guideline Development Group. British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax. 2003 Jun;58(6):470-484. PMID: 12775856
  4. American College of Emergency Physicians Clinical Policies Committee; Clinical Policies Committee Subcommittee on Suspected Pulmonary Embolism. Clinical policy: critical issues in the evaluation and management of adult patients presenting with suspected pulmonary embolism. Ann Emerg Med. 2003 Feb;41(2):257-270. PMID: 12548278
  5. Goldhaber SZ. Modern treatment of pulmonary embolism. Eur Respir J Suppl. 2002 Feb;35:22S-27S. PMID: 12064677
  6. Iles S, Beckert L, Than M, et al. Making a diagnosis of pulmonary embolism - new methods and clinical issues. N Z Med J. 2003 Jul;116(1177):U499. PMID: 12861313
  7. Hirsh J, Warkentin TE, Shaughnessy SG, et al. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest. 2001 Jan;119(1)(Suppl):S64-S94. PMID: 11157643
  8. Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008 Jun;133(6)(Suppl):454S-545S. PMID: 18574272
  9. Quinlan DJ, McQuillan A, Eikelboom JW. Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials. Ann Intern Med. 2004 Feb;140(3):175-183. PMID: 14757615
  10. Ramzi DW, Leeper KV. DVT and pulmonary embolism: Part II. Treatment and prevention. Am Fam Physician. 2004 Jun;69(12):2841-2848. PMID: 15222649
  11. Kearon C. Diagnosis of pulmonary embolism. CMAJ. 2003 Jan;168(2):183-194. PMID: 12538548
  12. Task Force on Pulmonary Embolism, European Society of Cardiology. Guidelines on diagnosis and management of acute pulmonary embolism. Eur Heart J. 2000 Aug;21(16):1301-1336. PMID: 10952823
  13. Stein PD, Woodard PK, Hull RD, et al. Gadolinium-enhanced magnetic resonance angiography for detection of acute pulmonary embolism: an in-depth review. Chest. 2003 Dec;124(6):2324-2328. PMID: 14665516
  14. Snow V, Qaseem A, Barry P, et al. Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med. 2007 Feb;146(3):204-210. PMID: 17261857
  15. Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J. 2008 Sep;29(18):2276-2315. doi: 10.1093/eurheartj/ehn310. Accessed 30 Aug 2008. PMID: 18757870
  16. Dupras D, Bluhm J, Felty C, et al. Institute for Clinical Systems Improvement. Venous thromboembolism diagnosis and treatment. 13th ed. 2013 Jan:001-91. Accessed 18 Sep 2012
  17. Creager MA, Dzau VJ. Vascular diseases of the extremities. In: Fauci AS, Braunwald E, Isselbacher KJ, et al. Harrison's Principles of Internal Medicine. 14th ed: McGraw-Hill; 1998:1404-1405
  18. Sue DY, Vintch JRE. Pulmonary disease. In: Bongard FS, Sue DY, Vintch JRE, eds. Current diagnosis & treatment critical care. 3rd ed. New York: McGraw-Hill; 2008:545-561
  19. MedWormhttp://www.medworm.com/rss/index.php/Pediatrics/33/http://www.medworm.com/rss/medicalfeeds/specialities/Pediatrics.xml
  20. MedWormhttp://www.medworm.com/rss/index.php/Respiratory-Medicine/40/http://www.medworm.com/rss/medicalfeeds/specialities/Respiratory-Medicine.xml
  21. Anticoagulants, antiplatelets and fibrinolystics. MIMS. www.mims.com. 2010. Accessed 13 Jan 2010
  22. Scottish Intercollegiate Guidelines Network. Prevention and management of venous thromboembolism: national meeting draft. SIGN. http://www.sign.ac.uk. Sep 2009. Accessed 13 Jan 2010
  23. Tapson VF. Massive pulmonary embolism. UpToDate. http://www.uptodate.com. 02 Sep 2004
  24. Institute for Clinical Systems Improvement (ICSI). Health care guideline: venous thromboembolism diagnosis and treatment. 9th ed. http://www.icsi.org. Feb 2009. Accessed 13 Jan 2010
  25. Tapson VF. Thrombolytic therapy in venous thromboembolism. UpToDate. http://www.uptodate.com. 02 Sep 2004. Accessed 26 Jan 2012.
  26. Ageno W, Gallus AS, Wittkowsky A, Crowther M, Hylek EM, Palareti G; American College of Chest Physicians. Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb;141(Suppl 2):e44S-88S. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278051/pdf/112292.pdf. PMID: 22315269
  27. Dupras D, Bluhm J, Felty C, et al. Institute for Clinical Systems Improvement (ICSI). Health care guideline: venous thromboembolism diagnosis and treatment. 13th ed. ICSI. https://www.icsi.org/. Jan 2013. Accessed 23 Apr 2015.
  28. Garcia DA, Baglin TP, Weitz JI, Samama MM; American College of Chest Physicians. Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb;141(Suppl 2):e24S-43S. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278070/pdf/112291.pdf. PMID: 22315264
  29. Linkins LA, Dans AL, Moores LK, et al; American College of Chest Physicians. Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb;141(Suppl 2):e495S-e530S. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278058/pdf/112303.pdf. Accessed 18 Jul 2014. PMID: 22315270
  30. Scottish Intercollegiate Guidelines Network (SIGN). Prevention and management of venous thromboembolism. SIGN publication no. 122. Scottish Intercollegiate Guidelines Network (SIGN). http://www.sign.ac.uk/pdf/sign122.pdf. 2010. Accessed 17 Jul 2014.
  31. Boehringer Ingelheim. FDA approves Pradaxa® (dabigatran etexilate mesylate) for treatment and reduction in the risk of recurrence of deep venous thrombosis and pulmonary embolism. Boehringer Ingelheim. http://us.boehringer-ingelheim.com/news_events/press_releases/press_release_archive/2014/04-07-14-fda-approves-pradaxa-dabigatran-etexilate-mesylate-treatment-reduction-risk-of-recurrence-deep-venous-thrombosis-pulmonary-embolism.html#. April 2014. Accessed 11 Sep 2014.
  32. Schulman S, Kakkar AK, Goldhaber SZ, et al; RE-COVER II Trial Investigators. Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis. Circulation. 2014 Feb;129(7):764-772. http://circ.ahajournals.org/content/129/7/764.full.pdf. Accessed 11 Sep 2014. PMID: 24344086
  33. Scottish Intercollegiate Guidelines Network (SIGN). Antithrombotics: indications and management. SIGN publication no. 129. Scottish Intercollegiate Guidelines Network (SIGN). http://www.sign.ac.uk/pdf/SIGN129.pdf. June 2013. Accessed 11 Sep 2014.
  34. Kearon C, Akl EA, Ornelas J, et al. Antithrombotic therapy for VTE disease: CHEST Guideline and Expert Panel report. Chest. 2016 Feb;149(2):315-352. doi: 10.1016/j.chest.2015.11.026. Accessed 08 Jun 2016. PMID: 26867832
  35. Aggarwal V, Nicolais CD, Lee A, Bashir R. Acute management of pulmonary embolism. American College of Cardiology. https://www.acc.org/. Oct 2017.
Editor's Recommendations
Special Reports
MORE Special Reports arrow
Related Disease News
MORE Disease News arrow